Nomega-Nitro-L-arginine (L-NNA), Nitric oxide synthase inhibitor

Be the first to review this product! Submit a review

|

(4 Publications)

MW 219.2 Da, Purity >99%. Nitric oxide synthase inhibitor (K_i = 4.4 μM). Cardiovascular effects. Active in vivo.

View Alternative Names

BNOS, Constitutive NOS, EC-NOS, EP2, Endothelial NOS, Endothelial nitric oxidase synthase, Endothelial nitric oxide synthase, Endothelial nitric oxide synthase 3, HEP-NOS, Hepatocyte NOS, IHPS 1, Inducible NO synthase, Inducible NOS, Inducible nitric oxide synthase, MAC NOS, Macrophage NOS, N-NOS, NC-NOS, NOS, NOS III, NOS type I, NOS type II, NOS type III, NOS2A, NOS2A, Inducible, Hepatocyte, NOS2_HUMAN, NOS3_HUMAN, Neuronal NOS, Nitric oxide synthase, Nitric oxide synthase 1, Nitric oxide synthase 1 neuronal, Nitric oxide synthase 2 inducible, Nitric oxide synthase 2 inducible macrophage, Nitric oxide synthase 3, Nitric oxide synthase 3 (endothelial cell), Nitric oxide synthase 3 endothelial cell, Nitric oxide synthase brain, Nitric oxide synthase endothelial, Nitric oxide synthase inducible, Nos II, PE2R2_HUMAN, PGE receptor EP2 subtype, PGE2 receptor EP2 subtype, PTGER 2, Peptidyl-cysteine S-nitrosylase NOS2, Prostaglandin E receptor 2 EP2 subtype, Prostaglandin E receptor 2 subtype EP2, Prostaglandin E receptor 2 subtype EP2 53kDa, Prostaglandin E2 receptor, Prostaglandin E2 receptor EP2 subtype, Prostanoid EP2 receptor, cNOS, eNOS, iNOS, inducible, neuronal Nitric Oxide Synthase, nitric oxide synthase 2A (inducible, hepatocytes), nitric oxide synthase, macrophage